Shared decision-making in the management of patients with inflammatory bowel disease

Head-to-head trials in inflammatory bowel disease: past, present and future

(2020) Lieven Pouillon et al.   Nature Reviews Gastroenterology & Hepatology

Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab

(2020) Anne Hu et al.   Clinical Gastroenterology and Hepatology

Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications

(2020) Laura E Targownik et al.   Journal of Crohns & Colitis

Assessing Patient Decision-Making on Biologic and Small-Molecule Therapies in Inflammatory Bowel Diseases: Insights From a Conjoint Analysis in the United States, Canada, and the United Kingdom

(2020) Devin B Patel et al.   INFLAMMATORY BOWEL DISEASES

Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review

(2019) Dong Yeon Jeong et al.   AUTOIMMUNITY REVIEWS

In the absence of head-to-head trials, what do real world studies tell us about the comparative effectiveness of biologics in Crohn’s disease

(2019) Joseph Meserve et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

The Role of Early Biologic Therapy in Inflammatory Bowel Disease

(2019) Dana Rachel Berg et al.   INFLAMMATORY BOWEL DISEASES

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

(2019) Bruce E. Sands et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease

(2019) Qingdong Guan   Journal of Immunology Research

A comprehensive review and update on Crohn's disease

(2018) Mahesh Gajendran et al.   DM DISEASE-A-MONTH

Combination Immunosuppression in IBD

(2018) Steven Bots et al.   INFLAMMATORY BOWEL DISEASES

Patients’ perception of their involvement in shared treatment decision making: Key factors in the treatment of inflammatory bowel disease

(2018) Sophie Veilleux et al.   PATIENT EDUCATION AND COUNSELING

Cultural adaptation and validation of patient decision aids: a scoping review

(2018) Vanessa Chenel et al.   Patient Preference and Adherence

Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device

(2018) Larry A. Allen et al.   JAMA Internal Medicine

Management of inflammatory bowel disease

(2018) Emily K Wright et al.   MEDICAL JOURNAL OF AUSTRALIA

Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis

(2018) Belinda Jackson et al.   Expert Review of Gastroenterology & Hepatology

Systematic Review and Meta-analysis

(2017) Jean M. Chalhoub et al.   INFLAMMATORY BOWEL DISEASES

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

(2017) Magali Lemaitre et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

P353 Long-term safety of adalimumab in patients with Crohn's disease: final data from PYRAMID registry

(2017) G. D'Haens et al.   Journal of Crohns & Colitis

European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease

(2017) Glen Doherty et al.   Journal of Crohns & Colitis

Crohn's disease

(2017) Joana Torres et al.   LANCET

Ulcerative colitis

(2017) Ryan Ungaro et al.   LANCET

Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs

(2017) Jennifer Lofland et al.   Patient Preference and Adherence

A three-talk model for shared decision making: multistage consultation process

(2017) Glyn Elwyn et al.   BMJ-British Medical Journal

A three-talk model for shared decision making: multistage consultation process

(2017) Glyn Elwyn et al.   BMJ-British Medical Journal

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients

(2016) Ryuji Morishige et al.   ADVANCES IN THERAPY

Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis

(2016) Shailja C. Shah et al.   Clinical Gastroenterology and Hepatology

Development of an index to define overall disease severity in IBD

(2016) Corey A Siegel et al.   GUT

Systematic review with meta-analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis

(2015) D. Christophorou et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease

(2015) S. C. Shah et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus

(2015) Brian Bressler et al.   GASTROENTEROLOGY

Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis

(2015) Sanjay K. Murthy et al.   INFLAMMATORY BOWEL DISEASES

Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers

(2013) Lyndal J Trevena et al.   BMC Medical Informatics and Decision Making

Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease

(2013) Brian G. Feagan et al.   GASTROENTEROLOGY

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

(2013) Remo Panaccione et al.   GASTROENTEROLOGY

Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease

(2013) Mark T. Osterman et al.   GASTROENTEROLOGY

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

(2013) Laurent Peyrin-Biroulet et al.   GUT

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

(2013) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Using a ‘talk’ model of shared decision making to propose an observation-based measure: Observer OPTION5 Item

(2013) Glyn Elwyn et al.   PATIENT EDUCATION AND COUNSELING

A Pooled Analysis of Infections, Malignancy and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease

(2012) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

(2012) S. Schreiber et al.   Journal of Crohns & Colitis

Shared Decision Making: A Model for Clinical Practice

(2012) Glyn Elwyn et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Shared Decision Making — The Pinnacle of Patient-Centered Care

(2012) Michael J. Barry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Zu welchen Themen wünschen Patientinnen und Patienten mit Morbus Crohn oder Colitis ulcerosa mehr Informationen und welche eigene Rolle bevorzugen sie bei medizinischen Behandlungsentscheidungen? Ergebnisse einer Betroffenenbefragung in Deutschland

(2012) S. Conrad et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Tumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety

(2012) Benjamin Ngo et al.   Current Molecular Pharmacology

Surgery for adult Crohn's disease: what is the actual risk?

(2011) G. Bouguen et al.   GUT

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

(2011) W. Reinisch et al.   GUT

Genetics and pathogenesis of inflammatory bowel disease

(2011) Bernard Khor et al.   NATURE

Systematic review: the costs of ulcerative colitis in Western countries

(2010) R. D. COHEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

(2010) Stefan Schreiber et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Patients’ Preferences regarding Shared Decision-Making in the Treatment of Inflammatory Bowel Disease: Results from a Patient-Empowerment Study

(2010) Judith E. Baars et al.   DIGESTION

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET

Evidence Based Medicine and Shared Decision Making: The challenge of getting both evidence and preferences into health care

(2008) Alexandra Barratt   PATIENT EDUCATION AND COUNSELING